Can Your Pharmacy Cure All This?

Efanesoctocog alfa is a recombinant factor VIII therapy with once-a-week dosing.

As inflation rises, consumers are beginning to lose confidence in their ability to cover health care expenses.

Collections of oncology drugs in 13 states are being redistributed to patients in need.

Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.

Anacaulase-bcdb improves current standard of care for deep partial thickness and/or full thickness thermal burns.

Prevalence of IBD doubled between 1995 and 2016 and exposure to antibiotics may be to blame.